drugset / Trial / NCT02535104
Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Ranpirnase in topical formulation is an antiviral drug being evaluated for the topical treatment of anogenital warts. The aims of this study is to evaluate the efficacy and safety of a topical formulation of ranpirnase in subjects with genital warts.
Timeline
- Start
- 2016-02
- Primary completion
- 2016-09
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ranpirnase | Protein / enzyme biologic | 1 mg/ml | Topical |